BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 18627649)

  • 41. Probiotics in the management of irritable bowel syndrome and inflammatory bowel disease.
    Whelan K; Quigley EM
    Curr Opin Gastroenterol; 2013 Mar; 29(2):184-9. PubMed ID: 23286925
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical trial: transcutaneous interferential electrical stimulation in individuals with irritable bowel syndrome - a prospective double-blind randomized study.
    Coban Ş; Akbal E; Köklü S; Köklü G; Ulaşlı MA; Erkeç S; Aktaş B; Yüksel O; Koçak E; Erdem HR
    Digestion; 2012; 86(2):86-93. PubMed ID: 22846190
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Probiotics in functional bowel disorders.
    Hod K; Ringel Y
    Best Pract Res Clin Gastroenterol; 2016 Feb; 30(1):89-97. PubMed ID: 27048900
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review.
    Moayyedi P; Ford AC; Talley NJ; Cremonini F; Foxx-Orenstein AE; Brandt LJ; Quigley EM
    Gut; 2010 Mar; 59(3):325-32. PubMed ID: 19091823
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bugs and irritable bowel syndrome: The good, the bad and the ugly.
    Ghoshal UC; Park H; Gwee KA
    J Gastroenterol Hepatol; 2010 Feb; 25(2):244-51. PubMed ID: 20074148
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Probiotics in Irritable Bowel Syndrome: An Up-to-Date Systematic Review.
    Dale HF; Rasmussen SH; Asiller ÖÖ; Lied GA
    Nutrients; 2019 Sep; 11(9):. PubMed ID: 31480656
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy of Bifidobacterium infantis 35624 in patients with irritable bowel syndrome: a meta-analysis.
    Yuan F; Ni H; Asche CV; Kim M; Walayat S; Ren J
    Curr Med Res Opin; 2017 Jul; 33(7):1191-1197. PubMed ID: 28166427
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Is irritable bowel syndrome an infectious disease?
    Thompson JR
    World J Gastroenterol; 2016 Jan; 22(4):1331-4. PubMed ID: 26819502
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bacterial flora in irritable bowel syndrome: role in pathophysiology, implications for management.
    Quigley EM
    J Dig Dis; 2007 Feb; 8(1):2-7. PubMed ID: 17261128
    [TBL] [Abstract][Full Text] [Related]  

  • 50. British Dietetic Association systematic review of systematic reviews and evidence-based practice guidelines for the use of probiotics in the management of irritable bowel syndrome in adults (2016 update).
    McKenzie YA; Thompson J; Gulia P; Lomer MC;
    J Hum Nutr Diet; 2016 Oct; 29(5):576-92. PubMed ID: 27265510
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gastrointestinal microbiota in irritable bowel syndrome: their role in its pathogenesis and treatment.
    Parkes GC; Brostoff J; Whelan K; Sanderson JD
    Am J Gastroenterol; 2008 Jun; 103(6):1557-67. PubMed ID: 18513268
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy and safety of Bacillus coagulans LBSC in irritable bowel syndrome: A prospective, interventional, randomized, double-blind, placebo-controlled clinical study [CONSORT Compliant].
    Gupta AK; Maity C
    Medicine (Baltimore); 2021 Jan; 100(3):e23641. PubMed ID: 33545934
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tegaserod for the treatment of irritable bowel syndrome and chronic constipation.
    Evans BW; Clark WK; Moore DJ; Whorwell PJ
    Cochrane Database Syst Rev; 2007 Oct; (4):CD003960. PubMed ID: 17943807
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy and Safety of New
    Oh JH; Jang YS; Kang D; Chang DK; Min YW
    Nutrients; 2019 Nov; 11(12):. PubMed ID: 31783597
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bifidobacterium infantis 35624: a novel probiotic for the treatment of irritable bowel syndrome.
    Brenner DM; Chey WD
    Rev Gastroenterol Disord; 2009; 9(1):7-15. PubMed ID: 19367213
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Guidelines for the treatment of irritable bowel syndrome].
    Kwon JG; Park KS; Park JH; Park JM; Park CH; Lee KJ; Park HJ; Rhee JC;
    Korean J Gastroenterol; 2011 Feb; 57(2):82-99. PubMed ID: 21350320
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Manipulation of the Microbiota Using Probiotics.
    Grimm V; Riedel CU
    Adv Exp Med Biol; 2016; 902():109-17. PubMed ID: 27161354
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Symbiotics in irritable bowel syndrome--better than probiotics alone?
    Gracie DJ; Ford AC
    Curr Opin Clin Nutr Metab Care; 2015 Sep; 18(5):485-9. PubMed ID: 26107141
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Irritable bowel syndrome: a mild disorder; purely symptomatic treatment.
    Prescrire Int; 2009 Apr; 18(100):75-9. PubMed ID: 19585728
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical applications of probiotics in gastrointestinal disorders in children.
    Chen CC; Walker WA
    Natl Med J India; 2011; 24(3):153-60. PubMed ID: 21786845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.